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Abstract
A new magnesium complex of quinolone antibacterial agem was prepared. This new complex as well as a
previously isolated complex of magnesium with ciprofloxacin were tested against various Gram positive and
Gram negative microorganisms. Antimicrobial activities were evaluated using the agar diffusion test. The
results have shown that all magnesium complexes are significantly less active than the parent quinolone
drugs. It was also found that the activity of quinolones is reduced when the solutions of quinolones are
titrated with magnesium ions.
Introduction
The quinolones represent a big family of synthetic antibacterial agents which are in broad use to cure several
infectious diseases. Ciprofloxacin (cf l-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-
3-carboxylic acid) is one of typical members of the group whereas the second quinolone used in this study
(FCl=l-cyclopropyl-7-chloro-6-fluoro-4-oxo-l,4-dihydroquinoline-3-carboxylic acid) is only a precursor of
cf and is not used in clinical practice (Scheme 1).
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Scheme 1: Chemical formulae of ciprofloxacin (left) and FCI (fight).
It was found that the absorption of the quinolone drugs is lowered when they are consumed simultaneously
with magnesium or aluminium antacids (Polk, 1989; Lomaestro and Bailie, 1991). Many other ions (Ca, Fe,
Zn...) found in pharmaceuticals exert similar effects to quinolones (Shiba et al., 1994). The proposed reason
for such behaviour could be the chelate bonding of the quinolone to the metal. This was one of the reasons
that many authors started to study the interactions of metal ions and quinolones.
On the other hand, it seems that the role of metal ions is essential for the mode of action of these drugs. The
activity of quinolones is due to the inhibition of the supercoiling of DNA catalyzed by the metalloenzyme
DNA gyrase and it is also assumed that copper or iron complexes enable the bonding of the quinolone to the
DNA (Shen and Pemet, 1985; Crumplin et al., 1980). Conflicting reports have appeared in the literature on
the molecular details of drug-DNA and drug enzyme interactions. The first drug-DNA models have been
proposed by Shen and co-authors (Shen et al., 1989) and have included hydrogen bond type interactions
between the DNA unpaired bases and the quinolone, as well as a stacked dimerization of the drug. These
models have been modified and imply a possible interaction between the C-7 substituent and the quinolone
pocket on the B subunit of DNA gyrase (Morrissey et al., 1996). It was also discovered tlmt metal ions,
especially magnesium, are involved in such interactions (Palu et al., 1992). It was suggested that magnesium
acts as a bridge between the quinolone and the phosphate groups of the DNA. Recently, another model based
on the intercalation of quinolone into the double helix of DNA was proposed (Llorente et al., 1996). The
structure is stabilized by the binding of the magnesium ion with oxygen atoms present in quinolone, a
phosphate and a purine base of the DNA.
Our aim was to isolate new magnesium compounds of quinolones apart from those already prepared
(ZupanO6 and Bukovec, 1996; Turel et al., 1996) and to compare the biological activity of these compounds
against different microorganisms.
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Materials and Methods
Synthesis
Mg(FCI)2H20 (abbreviation MgFC1)
The quinolone (FC1) (154 mg) was dissolved in 35 mL of acetone. 70.1 mg of Mg(NO3)26HzO was added
and the solution was stirred and slightly heated. After few minutes the white product precipitated. After few
hours the product was filtered out and washed with water and acetone. Finally the product was left in a drier
at 50C for one hour. It was found that the isolated sample corresponds to formula Mg(FCI-)z H20.
Found: C, 51.80; H, 2.91; N, 4.81; Mg, 4.15. C6H18NzOTFzC12Mg requires C, 51.72; H, 2.98; N, 4.64; Mg,
4.03 %.
The same product was isolated if MgCI’6HO or Mg(CIO)zxH20 were used as reactants. All attempts to
prepare the crystals suitable for X-ray analysis have failed.
The product is only sparingly soluble in water and in different organic solvents.
[Mg(cf)2(HzO)212HzO (abbreviation Mgcf)
The product Mgcfwas prepared as reported elsewhere (Zupan6i6 and Bukovec, 1996).
Analyses and PhysicalMeasurements
The analyses of carbon, hydrogen and nitrogen were carded out on a Perkin-Elmer 204C microanalyzer.
The magnesium ion content has been determined by a titration with the ethylenediaminetetraacetic acid
(EDTA). First the decomposition of the complex was performed as follows. 50.0 mg of sample MgFC1 was
dissolved in the mixture of 1.32 mL of concentrated nitric acid and 0.33 mL of sulphuric acid in a Kjehldahl
flask. The mixture was heated till all the liquid evaporated. The residue was dissolved in the 100.0 mL of
distilled water. The aliquot of the sample (25.0 mL) was transferred to the Erlenmeyer flask and the buffer
solution (pH 10) was added. The sample was titrated with 0.010 M EDTA solution and the indicator
Eriochrome black T was used for the determination of the end point (Welcher, 1958).
Infrared spectra were recorded in the solid state on Nujol mulls between CsI windows on a Perkin-Elmer
1720X FT-IR spectrometer. Conditions: range 4000-220 cm
1 resolution 2 cm1, number of scans 10.
Antimicrobial activity tests
The following bacterial strains were used: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus
salivarius, Streptococcus lactis, Streptococcusfoecalis, Micrococcus luteus, Bacillus cereus, Bacillus subtilis,
Aeromonas sp., Salmonella enteritidis, Escherichia coil Enterobacter aerogenes, Proteus vulgaris,
Klebsiella pneumoniae, Pseudomonas aeruginosa, Pseudomonas fluorescens and Shigella sonnei. All the
used bacterial strains were obtained from the local collection at the Department of Biology, University of
Ljubljana.
Antimicrobial activities were evaluated using the agar diffusion test. The tested bacteria were allowed to grow
overnight and their concentration was then determined. Bacterial culture was incorporated to Lauria Broth
nutrient agar which was previously cooled to 42 C. The final concentration of bacteria was approximately
5 105 CFU/mL (CFU colony forming unit). Twenty millilitres of inoculated medium was poured into petri
dishes and kept at 4C until use. Circles of agar ( 1 cm) were cut out from the cooled medium.
The MIC (minimal inhibitory concentration) values of Mgcf, FCI and MgFC1 were determined, using
ciprofloxacin and ciprofloxacin hydrochloride (cfHCl) as a reference substances. MIC represents the lowest
concentration of an antibiotic that will inhibit the growth of a tested organism. For estimating MIC, the
antibacterial substances were diluted gradually in 10 nM potassium phosphate buffer pH 7.4, containing 2 %
DMSO. Hundred millilitres of each dilution were poured into the holes cut in the inoculated medium, after
that the system was kept at 37C for 24 h. Finally, the diameters of inhibition zones were measured.
Additionally we wanted to check if there was any difference in the biological activity between the magnesium
complexes and the samples in which we added free magnesium ions to the solutions containing
ciprofloxacin.
The effect of magnesium ions on the antibacterial activity of ciprofloxacin was tested as follows:
ciprofloxacin was diluted in 10 mM potassium phosphate buffer pH 7.4, containing 2 % DMSO. The final
concentration of cf was 30 tg/mL. Fifty microlitres of ciprofloxacin were mixed with the same volume of
different MgC12 dilutions in the same buffer. Agar diffusion test was used to determine the antibacterial
activity, as described above. The tested microorganism was S. aureus.
Results and Discussion
The proposed structure ofthe complexes
The infrared spectra of quinolones are quite complex and we only compared the most indicative vibrations of
the samples used also in our previous studies (Turel et al., 1994; Turel et al., 1997; Turel et al., 1999). In the
infrared spectrum of the free quinolone FCI we can assign the valence vibration of the carboxylic group
v(C=O)c .group at 1723 cm" and the valence vibration of the ring carbonyl group at position 4 v(C=O)p at
1607 cmt. In the magnesium complex MgFCI a strong broad band appeared at 1626 cm. The absence of the
v(C=O)c and the shift of v(C=O)p vibrations could be the evidence that these groups are involved in the
bonding to the metal. The changes in the IR spectra ofMgcf are similar and were described before (Zupan6i6
and Bukovec, 1996). A similar infrared spectrum was found for the copper(II) complexes of ciprofloxacin
102Iztok Turel et aL Metal-Based Drugs
(Turel et al., 1994; Turel et al., 1999). The X-ray structure of this copper complex- [CtI(cf)2]CI2"6H20
revealed that copper is bidentately bonded to the quinolone through oxygen atom of the carboxylic group and
oxygen atom of the ring earbonyl group. Such bonding was found also in some other metal complexes of
quinolones (Baenziger et al., 1986; Chulvi et al., 1991; Ruiz et al., 1994; Koppenhoefer et al., 1995; Ruiz et
al., 1995; Ruiz et al., 1997; Ruiz et al., 1998; Turel et al., 1999). According to these facts we assume that the
bonding in magnesium complex ofMgFC1 is similar (Scheme 2).
/\
Scheme 2: The proposed bonding of magnesium to the quinolone.
Table 1. Antibacterial activity of cf, cfHCl, Mgcf, FCI and MgFCI. The activity is expressed as the MIC
(minimal inhibitory concentration, which is the lowest concentration of an antibiotic that inhibits the growth
of a tested organism). MIC (tg/mL)
Microorganism cf cfHC! Mgcf FC! MgFC!
Staphylococcus aureus 1 1.2 1.2 2 30
Staphylococcus epidermidis 2.5 2.5 5 25 500
Streptococcus salivarius 0.02 0.02 0.2 1 7
,Streptococcus lactis 3 3 6 60 70
Streptococcusfoecalis 1 1.5 5 80 lO0
Micrococcus luteus 10 10 25 100 500
Bacillus cereus 1 1 1.5 0.6 3.5
Bacillus subtilis 0.5 0.5 0.5 0.5 1
Enterobacter aerogenes 1 1.5 2 5 50
Escherichia coli 0.05 0.05 15 2 25
Proteus vulgaris O. 1 O. 1 0.25 0.75 5
Klebsiella pneumoniae O. 1 O. 1 0.25 2 60
Pseudomonas aeruginosa 0.5 0.5 0.5 1O0 500
Pseudomonasfluorescens 0.25 0.25 l 25 500
Aeromonas sp. 0.025 0.025 0.4 0.05 0.4
Shigella sonnei O. 1 O. 1 0.25 0.75 10
,Salmonella enteritidis 0.25 0.25 0.25 1 10
Antimicrobial activity tests
The susceptibility of the bacteria to the tested agents is presented in Table 1. All the tested compounds
showed approximately the same antibacterial activities against Gram positive and Gram negative bacteria.
However, there is a difference in the susceptibility to the same antibiotic compound among different bacterial
strains. The activity of Mgcf is about two folds lower than the activity of the reference compounds, cf and
cfHC1.
The intermediate FCI and its magnesium complex MgFCI have remarkably lower antimicrobial activities
comparing to the references. This is especially notable with MgFCI, which activity in some cases (K.
pneumoniae) is even 30 fold lower as compared to FCI, or 600 fold lower as compared to cf. It seems that the
introduction ofmagnesium into the ciprofloxacin molecule affects its antibacterial activity by diminishing it.
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The same effect is observed when cf is titrated with increasing concentration of MgCI2 (0-500 mM) (Figure
1). Magnesium decreases the antibacterial activity of ciprofloxacin even at very low concentrations. The loss
of activity is especially notable at the MgCI2 concentrations above 1 mM.
We can thus conclude that the activity ofquinolones is remarkably lowered in the presence of magnesium ion
both in the complexed or free form.
Figure 1. The effect ofMg
2+ on the antibacterial activity of ciprofloxacin. The antibiotic was titrated with
increasing concentration of MgCI2, and the activity was measured using agar diffusion test. The final
concentration of ciprofloxacin was 15 Ig/mL, and the tested microorganism was Staphylococcus aureus.
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